{"product_id":"pharma-and-profits-balancing-innovation-medicine-and-drug-prices-paperback-softback-9781119881339","title":"Pharma and Profits; Balancing Innovation, Medicine, and Drug Prices (Paperback \/ softback) 9781119881339","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePharma and Profits\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eBalancing Innovation, Medicine, and Drug Prices\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn L. LaMattina (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781119881339, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 23 September 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e112 pages\u003cbr\u003e22.6 x 15 x 0.8 cm, 0.136 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eHigh-level commentary on various facets of the pharmaceutical industry from a key leader in the field\u003c\/b\u003e \u003c\/p\u003e\n\u003cp\u003eThis book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. \u003c\/p\u003e\n\u003cp\u003eWritten by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: \u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eFiscal consequences of curing hepatitis C\u003c\/li\u003e \u003cli\u003emRNA vaccines and the race for a cure\u003c\/li\u003e \u003cli\u003eWhy the government does not deserve a piece of Biopharma’s profits\u003c\/li\u003e \u003cli\u003ePaying for drugs whose ultimate value is unknown\u003c\/li\u003e \u003cli\u003eThe impact of reduced revenues on R\u0026amp;D\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eAcknowledgments ix\u003c\/p\u003e \u003cp\u003eIntroduction x\u003cbr\u003e\u003cbr\u003eChapter 1 The $1000 Pill: the Fiscal Consequences of Curing Hepatitis C 1\u003c\/p\u003e \u003cp\u003eChapter 2 Enter the Payers: Fda Approval Does Not Guarantee Commercial Success 10\u003c\/p\u003e \u003cp\u003eChapter 3 Pandemic: mRNA Vaccines And The Race For A Cure 19\u003c\/p\u003e \u003cp\u003eChapter 4 Federal Investment in R\u0026amp;d: Why the Government Does Not Deserve a Piece of Biopharma’s Profits? 34\u003c\/p\u003e \u003cp\u003eChapter 5 Insulin: the True Cost of a 100- Year- Old Drug 44\u003c\/p\u003e \u003cp\u003eChapter 6 The Costly Alzheimer’s Disease Drug: a Questionable Breakthrough 50\u003c\/p\u003e \u003cp\u003eChapter 7 Gene Therapy: How Much Is a Life Worth? 60\u003c\/p\u003e \u003cp\u003eChapter 8 Proving the Value of Expensive Drugs: Should We Pay For Drugs Whose Ultimate Value Is Unknown? 70\u003c\/p\u003e \u003cp\u003eChapter 9 Generic Drugs: Built- in Cost Controls 74\u003c\/p\u003e \u003cp\u003eChapter 10 About Those Soaring Pharma Profits: Are They Driving Healthcare Costs? 80\u003c\/p\u003e \u003cp\u003eChapter 11 Schemes to Lower Drug Prices: the Impact of Reduced Resources on R\u0026amp;d 84\u003c\/p\u003e \u003cp\u003eFinal Thoughts 96\u003c\/p\u003e \u003cp\u003eIndex 98\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Chemistry [\u003ca title=\"See our other books on Chemistry\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Chemistry%20%5BPN%5D%22\"\u003ePN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52449457307928,"sku":"9781119881339","price":18.56,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781119881339.jpg?v=1785200275","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/pharma-and-profits-balancing-innovation-medicine-and-drug-prices-paperback-softback-9781119881339","provider":"Freshly Printed Books","version":"1.0","type":"link"}